NSC |
Compound |
Enrichment |
Correlation |
NSC 746930 |
Null |
0.0126882509540132 |
0.060340518 |
NSC 87221 |
Actinomycin D, 2A-D-alloisoleucine- (9CI) |
0.0126882509540132 |
0.11375861 |
NSC 89671 |
Ascotoxin |
0.0126882509540132 |
-0.305391 |
NSC 105014 |
Cladribine |
0.0126882509540134 |
0.42253016 |
NSC 129794 |
Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) |
0.0126882509540134 |
0.0037443912 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.0126882509540134 |
0.45789685 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.0126882509540134 |
0.24391736 |
NSC 328410 |
Camptothecin Derivative |
0.0126882509540134 |
0.51275705 |
NSC 33570 |
Null |
0.0126882509540134 |
0.41151507 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0126882509540134 |
0.36212432 |